Target intelligence / Profile preview

General transcription factor IIH subunit 3 (GTF2H3) (GTF2H3)

Target
GTF2H3
Molecular classification
Transcription factor, TFIIH complex subunit, Zinc-binding protein
01

Overview

General transcription factor IIH subunit 3 (GTF2H3), also known as p34, is a core component of the multi-subunit TFIIH complex, which is essential for both RNA polymerase II-mediated transcription and nucleotide excision repair (NER) (UniProt Q13889). Within the TFIIH core, GTF2H3 interacts with other subunits like p44 (GTF2H2) to provide structural stability and facilitate the assembly of the holoenzyme required for promoter opening and escape (GeneCards; NIH). Dysregulation of GTF2H3 and the TFIIH complex is associated with various cancers, including endometrial and bladder cancer, as well as genetic repair disorders like Cockayne syndrome and xeroderma pigmentosum (Wikipedia). Because cancer cells often exhibit "transcriptional addiction," the TFIIH complex has emerged as a significant therapeutic target (NIH). While most current inhibitors like triptolide and THZ1 target the enzymatic subunits XPB and CDK7 respectively, GTF2H3 is a critical structural node whose disruption can lead to complex instability and cell death (NIH; Open Targets). Consequently, targeting the protein-protein interactions of GTF2H3 represents a potential strategy for developing novel anti-cancer agents that induce global transcriptional collapse in malignant cells.

Other names
TFIIH subunit 3p34BTF2 p34General transcription factor IIH polypeptide 3TFB4
02

Mechanism of action

Inhibition of the TFIIH complex, leading to the suppression of RNA polymerase II-mediated transcription and nucleotide excision repair.

03

Biological functions

Transcription initiationNucleotide excision repairRNA polymerase II promoter openingDNA unwinding
04

Disease associations

CancerCockayne syndromeTrichothiodystrophyXeroderma pigmentosum
05

Safety considerations

Systemic toxicityInhibition of global transcriptionImpaired DNA repairEssential gene lethality
06

Interacting drugs

Triptolide

3 more in the full profile.

07

Biomarkers

GTF2H3 mRNA expressionTFIIH complex activity

Beyond the preview

Go deeper on General transcription factor IIH subunit 3 (GTF2H3) (GTF2H3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor IIH subunit 3 (GTF2H3) (GTF2H3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call